GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Odyssey Group International Inc (OTCPK:ODYY) » Definitions » Debt-to-EBITDA

Odyssey Group International (Odyssey Group International) Debt-to-EBITDA : 0.03 (As of Jan. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Odyssey Group International Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Odyssey Group International's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was $1.49 Mil. Odyssey Group International's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was $0.00 Mil. Odyssey Group International's annualized EBITDA for the quarter that ended in Jan. 2024 was $53.68 Mil. Odyssey Group International's annualized Debt-to-EBITDA for the quarter that ended in Jan. 2024 was 0.03.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Odyssey Group International's Debt-to-EBITDA or its related term are showing as below:

ODYY' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -2.79   Med: -0.2   Max: 0.13
Current: 0.13

During the past 9 years, the highest Debt-to-EBITDA Ratio of Odyssey Group International was 0.13. The lowest was -2.79. And the median was -0.20.

ODYY's Debt-to-EBITDA is ranked better than
84.19% of 430 companies
in the Medical Devices & Instruments industry
Industry Median: 1.235 vs ODYY: 0.13

Odyssey Group International Debt-to-EBITDA Historical Data

The historical data trend for Odyssey Group International's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Odyssey Group International Debt-to-EBITDA Chart

Odyssey Group International Annual Data
Trend Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only -0.03 -0.07 -0.05 -0.20 -0.41

Odyssey Group International Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.31 -0.44 -0.82 -1.70 0.03

Competitive Comparison of Odyssey Group International's Debt-to-EBITDA

For the Medical Devices subindustry, Odyssey Group International's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Odyssey Group International's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Odyssey Group International's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Odyssey Group International's Debt-to-EBITDA falls into.



Odyssey Group International Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Odyssey Group International's Debt-to-EBITDA for the fiscal year that ended in Jul. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(2.145 + 0) / -5.302
=-0.40

Odyssey Group International's annualized Debt-to-EBITDA for the quarter that ended in Jan. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1.485 + 0) / 53.68
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jan. 2024) EBITDA data.


Odyssey Group International  (OTCPK:ODYY) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Odyssey Group International Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Odyssey Group International's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Odyssey Group International (Odyssey Group International) Business Description

Traded in Other Exchanges
N/A
Address
2300 West Sahara Avenue, Suite 800 - No. 4012, Las Vegas, NV, USA, 89102
Odyssey Group International Inc is a company focused on developing life-saving medical products, Odyssey's goal is to create, acquire and accumulate distinct assets, intellectual property, and technologies that provide meaningful medical solutions. The Company is focused on building and acquiring assets in areas that have an identified technological advantage, provide superior clinical utility, and have a substantial market opportunity.
Executives
Erik C. Emerson other: Chief Commercial Officer 2300 WEST SAHARA AVENUE, SUITE 800 - #4012, LAS VEGAS NV 89102
Gregory W Gironda other: Chief Operating Officer 2300 WEST SAHARA AVENUE, SUITE 800 - #4012, LAS VEGAS NV 89102
Ricky Richardson director 2372 MORSE AVE., IRVINE CA 92614
Christine Farrell officer: Controller/Secretary 2372 MORSE AVE, IRVINE CA 92614
John P Gandolfo director 62 TERRACE ROAD, WAYNE NJ 07470
Jerome H Casey director 2372 MORSE AVE, IRVINE CA 92614
Jeffrey X Conroy director 2372 MORSE AVE, IRVINE CA 92614
Vanlandingham Jacob Ph.d director 2372 MORSE AVE, IRVINE CA 92614
J Michael Redmond director, officer: President/CEO 10 CANTERBURY ROAD, WINDHAM NH 03087

Odyssey Group International (Odyssey Group International) Headlines

From GuruFocus